STRENDENZ
LIVE

Serial Number

79295632

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Sep 8, 2020

Add to watchlist:

No watchlists yet
View on USPTO

STRENDENZ Trademark

Serial Number: 79295632 • Registration: 6443597

STRENDENZ is a trademark filed by NOVARTIS AG on September 8, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

September 8, 2020

Registration Date

August 10, 2021

Published for Opposition

May 25, 2021

Cancellation Date

April 2, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Oct 31, 2024 DENA
DEATH OF INTERNATIONAL REGISTRATION
Oct 31, 2024 DETH
DEATH OF INTERNATIONAL REGISTRATION
Oct 31, 2024 DETH
DEATH OF INTERNATIONAL REGISTRATION
Oct 30, 2024 DETH
DEATH OF INTERNATIONAL REGISTRATION
Oct 30, 2024 DETH
DEATH OF INTERNATIONAL REGISTRATION
Oct 30, 2024 DETH
DEATH OF INTERNATIONAL REGISTRATION
Oct 30, 2024 DETH
DEATH OF INTERNATIONAL REGISTRATION
Oct 30, 2024 DETH
DEATH OF INTERNATIONAL REGISTRATION
Oct 30, 2024 DETH
DEATH OF INTERNATIONAL REGISTRATION
Oct 30, 2024 DETH
DEATH OF INTERNATIONAL REGISTRATION
Oct 30, 2024 DETH
DEATH OF INTERNATIONAL REGISTRATION
Oct 30, 2024 DETH
DEATH OF INTERNATIONAL REGISTRATION
Oct 30, 2024 DETH
NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED
Oct 11, 2024 NCS7
CANCELLED SECTION 7-TOTAL
Oct 11, 2024 C7..
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 10, 2024 APRE
REQUEST FOR SECT 7 TOTAL SURRENDER FILED
Oct 4, 2024 C7RF
TEAS SECTION 7 SURRENDER RECEIVED
Oct 4, 2024 ES7S
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 20, 2022 FINV
GENERIC MADRID TRANSACTION SENT TO IB
Jan 24, 2022 XXSS
GENERIC MADRID TRANSACTION CREATED
Jan 24, 2022 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 10, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 10, 2021 R.PR
NOTIFICATION PROCESSED BY IB
May 30, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 25, 2021 NPUB
PUBLISHED FOR OPPOSITION
May 25, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 5, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 5, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 5, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 19, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 31, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 30, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 30, 2021 TROA
REFUSAL PROCESSED BY IB
Jan 30, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 2, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jan 2, 2021 RFRR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 16, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 16, 2020 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 16, 2020 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 16, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 16, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 16, 2020 COAR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 13, 2020 RFCR
NON-FINAL ACTION WRITTEN
Dec 12, 2020 CNRT
ASSIGNED TO EXAMINER
Dec 10, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 24, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 20, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 17, 2020 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Oct 8, 2020 SDRC